Rentokil Initial plc (RTO) Q2 2026 Earnings Call Transcript
Rentokil Initial plc (RTO) Q2 2026 Earnings Call July 30, 2026 4:30 AM EDT
Company Participants
Michael Duffy – CEO & Executive Director
Paul Edgecliffe-Johnson – CFO & Director
Conference Call Participants
Andrew Grobler – BNP Paribas, Research Division
William Kirkness – Bernstein Institutional Services LLC, Research Division
Annelies Vermeulen – Morgan Stanley, Research Division
Nicole Manion – UBS Investment Bank, Research Division
Suhasini Varanasi – Goldman Sachs Group, Inc., Research Division
Oliver Davies – Rothschild & Co Redburn, Research Division
Timothy Ramskill – BofA Securities, Research Division
James Rosenthal – Barclays Bank PLC, Research Division
Allen Wells – Jefferies LLC, Research Division
Jane Sparrow – JPMorgan Chase & Co, Research Division
James Beard – Deutsche Bank AG, Research Division
Presentation
Michael Duffy
CEO & Executive Director
Good morning, ladies and gentlemen, and thank you for joining us. It’s a pleasure to be with you. I look forward to speaking with many of you in the coming days ahead. In a few moments, Paul will provide you with details on our financial performance for the 6 months ending June 30. I’ll then come back to provide my first impressions and priorities for growth before taking questions.
Please note to ask a question today, you will need to dial the separate conference call number shown on our website or at the end of this presentation. I want to first thank our 65,000 colleagues we have at Rentokil that come to work every day with 2 simple goals: keep each other safe and take care of our customers, and they do so to the best of their abilities. Our frontline truly are heroes and make me proud to be wearing the same jersey.
For half 1, the main headlines of an encouraging set of results are good financial performance with further progress on revenue and profit and strong free cash flow conversion. We are